Acute and serious hematological disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with severe hematological tumors admitted to the hematological ICU ward; 2. Those with hematological tumor disease as the primary diagnosis; 3. Those willing to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Rheumatic immune disease on admission; 2. Acute myocardial infarction, acute stroke, or intracranial hemorrhage on admission; 3. Malignant arrhythmia; 4. Non-hematologic disease as the primary diagnosis; 5. Life expectancy less than the study duration due to other non-hematologic diseases; 6. Age less than 16 years or greater than 85 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All cause mortality;Relapse;Remission; | — |
Countries
China
Contacts
Department of Hematology, The First Affiliated Hospital of Soochow University